Shire PLC (ADR) (SHPG) was Initiated by Liberum to “Buy”. Liberum advised their investors in a research report released on May 6, 2016.
Many Wall Street Analysts have commented on Shire PLC (ADR). Shire PLC (ADR) was Initiated by Cantor Fitzgerald to “Buy” on Feb 26, 2016. Shire PLC (ADR) was Initiated by Guggenheim to “Neutral” on Feb 10, 2016.
On the company’s financial health, Shire PLC (ADR) reported $2.12 EPS for the quarter, beating the analyst consensus estimate by $ 1.11 according to the earnings call on Apr 29, 2016. Analyst had a consensus of $1.01. The company had revenue of $1709.00 million for the quarter, compared to analysts expectations of $1699.64 million. The company’s revenue was up 14.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.08 EPS.
Shire PLC (ADR) closed down -7.92 points or -4.25% at $178.46 with 32,89,464 shares getting traded on Wednesday. Post opening the session at $181.6, the shares hit an intraday low of $176.38 and an intraday high of $181.87 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
Shire plc is a biopharmaceutical company. The Company along with its subsidiaries is engaged in developing and marketing medicines for patients with rare diseases and other specialty conditions. The Company commercializes its products in the areas of Neuroscience Gastrointestinal (GI) Rare Diseases and Other therapeutic areas. The Companys products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSE VUXEN/ADUVANZ (lisdexamfetamine dimesylate) ADDERALL XR (mixed salts of a single-entity amphetamine) INTUNIV (extended release guanfacine) EQUASYM (methylphenidate hydrochloride) modified release (XL) BUCCOLAM LIALDA (mesalamine)/ MEZAVANT(mesalazine) PENTASA (mesalamine) RESOLOR (prucalopride) REPLAGAL (agalsidase alfa) VPRIV (velaglucerase alfa) FIRAZYR (icatibant) CINRYZE C1 esterase inhibitor (human) FOSRENOL (lanthanum carbonate) XAGRID/ AGRYLIN (anagrelide hydrochloride) and PLENADREN (modified release hydrocortisone).